Open AccessANALEPTIC PROPERTIES OF ROSUVASTATIN AND CQ10 COMBINATION
Author(s) -
Angarika Balakrishnan,
Ketaki Walimbe,
Saumya Awasthi,
Supriya Athreya,
Vaishali Saini
Publication year - 2021
Publication title -
international journal of medical and biomedical studies
Language(s) - English
Resource type - Journals
eISSN - 2589-8698
pISSN - 2589-868X
DOI - 10.32553/ijmbs.v5i5.1918
Subject(s) - rosuvastatin , dyslipidemia , medicine , cardiotoxicity , pharmacology , chemotherapy , disease
This article is an examination of the Analeptic properties of Rosuvastatin and cq10 (Ubiquinone) combination. The scientific development and subsequent analysis of the ability of two combinational drugs Rosuvastatin and cq10 to treat human disorders/ diseases by lowering cholesterol and displaying antioxidant activity respectively, continues to influence researchers all over the globe, today. This article examines the research done and published by researchers and scientists. Consideration of current trends and data in scientific queries demonstrates further aspects of Analeptic properties of Rosuvastatin and cq10 (Ubiquinone) combination. Additionally, this article explores options for Rosuvastatin and its effects on Dyslipidemia, glucose homeostasis and high-risk cardiovascular patients. This article also provides insights into Ubiquinone and its effects on cardiovascular diseases and hypertriglyceridemia. Lastly, from this article the combined effects of rosuvastatin and cq10 on cardiotoxicity, Ischemia and Induced Myopathy can also be gauged.
Keywords: Rosuvastatin Ubiquinone, Cardiovascular, Dyslipidemia, Ischemia